Medizinische Klinik und Poliklinik D, Experimentelle Nephrologie, Universitätsklinikum Münster, Domagkstr. 3a, 48149 Münster, Germany.
Expert Opin Drug Metab Toxicol. 2011 Feb;7(2):159-74. doi: 10.1517/17425255.2011.547474.
Membrane transporters are important determinants of in vivo drug disposition, therapeutic efficacy and adverse drug reactions. Many commonly used drugs are organic cations and substrates of organic cation transporters (OCTs). These transporters have a large binding site containing partially overlapping interaction domains for different substrates and are specifically distributed around the body. Consequently, drug interactions with these transporters can result in specific toxicity.
This review describes the general properties of OCT and illustrates their importance for the development of important drug toxicities using the examples of metformin and cisplatin. Additionally, this review discusses the role of OCT polymorphisms in the modulation of these toxic effects.
Understanding how drugs interact with membrane transporters is pivotally important in explaining the mechanisms of specific toxicities and also in designing new drugs or new therapeutic protective protocols by specific competition at the transporter. Defining the pharmacogenomics of these transporters will be essential to personalized medicine, enabling physicians to choose drugs for patients based on efficacy, availability, cost, safety, tolerability and convenience.
膜转运蛋白是影响体内药物处置、治疗效果和药物不良反应的重要决定因素。许多常用药物是有机阳离子,也是有机阳离子转运体(OCT)的底物。这些转运体具有一个大的结合位点,其中包含不同底物的部分重叠的相互作用域,并且在全身特定分布。因此,药物与这些转运体的相互作用可能导致特定的毒性。
本综述描述了 OCT 的一般特性,并通过二甲双胍和顺铂的例子说明了它们对重要药物毒性发展的重要性。此外,本综述还讨论了 OCT 多态性在调节这些毒性作用中的作用。
了解药物如何与膜转运体相互作用对于解释特定毒性的机制以及通过在转运体上的特异性竞争来设计新药物或新的治疗保护方案至关重要。定义这些转运体的药物基因组学对于个体化医疗至关重要,使医生能够根据疗效、可用性、成本、安全性、耐受性和便利性为患者选择药物。